NLRP3 and dilated cardiomyopathy: Elevated levels of NLRP3 inflammasomes, caspase-1, and IL-1β are observed in the peripheral blood of patients with dilated cardiomyopathy, with NLRP3 levels serving as an independent risk factor for readmission within 6 months (61).